683 Capital Management’s NKGen Biotech, Inc. Warrants NKGNW Stock Holding History

683 Capital Management’s Portfolio NKGNW Stock Details NKGNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-100,000	Closed	-$20K	–	173
2023 Q2	$20K	Hold	100,000	–	–	﹤0.01%	134
2023 Q1	$14K	Hold	100,000	–	–	﹤0.01%	262
2022 Q4	$8.49K	Hold	100,000	–	–	﹤0.01%	272
2022 Q3	$15K	Hold	100,000	–	–	﹤0.01%	204
2022 Q2	$26K	Hold	100,000	–	–	﹤0.01%	222
2022 Q1	$61K	Hold	100,000	–	–	﹤0.01%	300
2021 Q4	$115K	Hold	100,000	–	–	﹤0.01%	299
2021 Q3	$116K	Buy	+100,000	New	+$125K	﹤0.01%	188

Other funds holding NKGNW

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

ETH

Exos TFP Holdings New York $162M AUM 16.08% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

PSAMP

P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return

683 Capital Management's NKGNW Position: Q3 2023 in Review

683 Capital Management sold out of NKGen Biotech, Inc. Warrants (NKGNW) in Q3 2023, closing a stake of 100,000 shares — an estimated $20K sold.

683 Capital Management first reported a position in NKGNW in Q3 2021 and held it in 8 quarters. The position peaked at $116K in Q3 2021. 21 funds tracked by Wall St. Rank hold NKGNW as of Q3 2023.

683 Capital Management reported no remaining NKGen Biotech, Inc. Warrants position as of Q3 2023 after selling out during the quarter.
683 Capital Management sold 100,000 NKGen Biotech, Inc. Warrants shares in Q3 2023, an estimated $20K.
683 Capital Management first reported a position in NKGen Biotech, Inc. Warrants in Q3 2021 and held it in 8 quarters.
683 Capital Management's NKGen Biotech, Inc. Warrants position peaked at $116K in Q3 2021.
21 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Warrants as of Q3 2023.

Based on 683 Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.